Trials / Completed
CompletedNCT00287781
A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- Kern Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine |
Timeline
- Start date
- 2002-01-01
- Completion
- 2006-04-01
- First posted
- 2006-02-07
- Last updated
- 2008-01-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00287781. Inclusion in this directory is not an endorsement.